| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
ThermoGenesis Holdings Inc (NASDAQ: THMO)
THMO Technical Analysis
5
| As on 9th Jun 2023 THMO STOCK Price closed @ 1.31 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.46 & Strong Buy for SHORT-TERM with Stoploss of 0.90 we also expect STOCK to react on Following IMPORTANT LEVELS. |
THMOSTOCK Price
| Open | 1.44 | Change | Price | % |
| High | 1.44 | 1 Day | -0.13 | -9.03 |
| Low | 1.28 | 1 Week | 0.01 | 0.77 |
| Close | 1.31 | 1 Month | -0.74 | -36.10 |
| Volume | 237800 | 1 Year | 0.05 | 3.97 |
| 52 Week High 6.00 | 52 Week Low 0.09 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| THMO Daily Charts |
THMO Intraday Charts |
Whats New @ Bazaartrend |
THMO Free Analysis |
|
|
THMO Important Levels Intraday
| RESISTANCE | 1.62 |
| RESISTANCE | 1.52 |
| RESISTANCE | 1.46 |
| RESISTANCE | 1.40 |
| SUPPORT | 1.22 |
| SUPPORT | 1.16 |
| SUPPORT | 1.10 |
| SUPPORT | 1.00 |
THMO Forecast April 2024
| 4th UP Forecast | 2.12 |
| 3rd UP Forecast | 1.86 |
| 2nd UP Forecast | 1.7 |
| 1st UP Forecast | 1.54 |
| 1st DOWN Forecast | 1.08 |
| 2nd DOWN Forecast | 0.92 |
| 3rd DOWN Forecast | 0.76 |
| 4th DOWN Forecast | 0.5 |
THMO Weekly Forecast
| 4th UP Forecast | 1.64 |
| 3rd UP Forecast | 1.53 |
| 2nd UP Forecast | 1.47 |
| 1st UP Forecast | 1.40 |
| 1st DOWN Forecast | 1.22 |
| 2nd DOWN Forecast | 1.15 |
| 3rd DOWN Forecast | 1.09 |
| 4th DOWN Forecast | 0.98 |
THMO Forecast2024
| 4th UP Forecast | 13.99 |
| 3rd UP Forecast | 9.92 |
| 2nd UP Forecast | 7.41 |
| 1st UP Forecast | 4.9 |
| 1st DOWN Forecast | -2.28 |
| 2nd DOWN Forecast | -4.79 |
| 3rd DOWN Forecast | -7.3 |
| 4th DOWN Forecast | -11.37 |
ThermoGenesis Holdings Inc ( NASDAQ USA Symbol : THMO )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
THMO Business Profile
ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for chimeric antigen receptor (CAR-T) and other cell-based therapies. It markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company manufactures and markets AXP II Automated Cell Separation System, an automated cell separation system for isolating and retrieving stem, and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing, and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. It offers PXP Point-of-Care System, an automated sterile system for the automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; PXP-LAVARE System, an automated system designed to wash, re-suspend, and volume reduce cell suspensions; PXP-1000 System, an automated system for fast and reproducible separation of multiple cellular components from blood with minimal red blood cell contamination; and X-Series products, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, X-Mini for small scale cell purification, and X-BACS System under development for large scale cell purification. It also provides CAR-TXpress Platform that addresses the critical unmet need for large scale cellular processing and chemistry, manufacturing, and controls needs. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California. Address: 2711 Citrus Road, Rancho Cordova, CA, United States, 95742
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service